
Sign up to save your podcasts
Or


Rick Watson and Jessica Lesesky break down three stories reshaping the consumer and tech landscape. First, why GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are expected to unlock $13B in new retail spending — and which brands stand to win as 80% of users size down.
Then, Nike's latest innovation shake-up: new chief Andy Caine steps in as the stock slides 32%, with Project Amplify, Nike Mind, and Aerofit on the horizon.
The Watson Weekly Weekend edition is sponsored by Avalara - the agentic AI platform automating global tax and compliance for leading eCommerce brands. For more details: https://avalaratax.watsonweekly.com/
Finally, Amazon's $200B and Google's $185B infrastructure bets — and why Sundar Pichai spends an hour a week personally rationing compute.
Subscribe to the newsletter at watsonweekly.com.
By Watson Weekly5
3535 ratings
Rick Watson and Jessica Lesesky break down three stories reshaping the consumer and tech landscape. First, why GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are expected to unlock $13B in new retail spending — and which brands stand to win as 80% of users size down.
Then, Nike's latest innovation shake-up: new chief Andy Caine steps in as the stock slides 32%, with Project Amplify, Nike Mind, and Aerofit on the horizon.
The Watson Weekly Weekend edition is sponsored by Avalara - the agentic AI platform automating global tax and compliance for leading eCommerce brands. For more details: https://avalaratax.watsonweekly.com/
Finally, Amazon's $200B and Google's $185B infrastructure bets — and why Sundar Pichai spends an hour a week personally rationing compute.
Subscribe to the newsletter at watsonweekly.com.

2,221 Listeners

113,121 Listeners

102 Listeners

5,610 Listeners

10,254 Listeners

8,447 Listeners

1,132 Listeners

49 Listeners

1,480 Listeners

6 Listeners